Steven Collis, AmerisourceBergen CEO (Alex Brandon/AP Images)
September 16, 2022 02:20 PM EDT
Deals
Pharma

Amerisource­Ber­gen throws down near­ly $1.3B cash for Ger­man life sci­ences com­pa­ny

Nicole DeFeudis

Editor

Amerisource­Ber­gen earned a whop­ping $60.1 bil­lion last quar­ter, thanks in part to its dis­tri­b­u­tion of gov­ern­ment-owned Covid treat­ments. Now it’s time to rein­vest some of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times